April 3rd 2025
The study stated early recognition and aggressive treatment of childhood-onset MMP are essential to prevent permanent scarring.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Atopic dermatitis: Breaking it down
March 1st 2006National report ? More basic research into atopic dermatitis (AD) needs to be conducted to understand the subsets of the condition and to generate new therapies to expand the therapeutic choices for the patient, according to Lawrence Chan, M.D., professor and head of the department of dermatology at the University of Illinois. Specifically, differentiating between "intrinsic" and "extrinsic" AD is critical.
Understanding geriatric dermatology
March 1st 2006San Francisco ? Treating the 65 and older patient is becoming a growing issue in dermatology. While some 35 million Americans ? about one in every eight people ? are elderly today, the senior population is expected to increase to one in five people, or an estimated 70 million, by 2030, according to Wendy E. Roberts, M.D., a dermatologist in Rancho Mirage and assistant clinical professor of medicine at Loma Linda University Medical School, Loma Linda, Calif.
AAD, NJMRC protest FDA's 'black box' warning on eczema drugs
February 7th 2006Washington -- The American Academy of Dermatology and the National Jewish Medical and Research Center have issued statements protesting new "black box" cancer warnings the Food and Drug Administration (FDA) has ordered on two drugs used to treat eczema: Elidel Cream (Novartis ) and Protopic ointment (Astellas Pharma).
Dermatologist says topical therapies safe for atopic dermatitis tx
February 1st 2006Portland, Ore. - Recently concerns have arisen regarding chronic use of the calcineurin inhibitors, Elidel cream (Novartis) and Protopic ointment (Astellas), in treating atopic dermatitis because of their potential association with infection and malignancy.
Physician perspective on thread lifts
February 1st 2006As might be expected with any new cosmetic procedure, suture suspension, popularly known as "thread lift," has engendered significant media attention. Thread lift has been promoted on "Oprah," "Today" and "Good Morning America" as a "lunch-time facelift." More recently, articles in The New York Times and Allure magazine have questioned the predictability and longevity of results, and the potential for complications.
Biologics may be less toxic than other medications
February 1st 2006National report - Biologic agents will not necessarily be more effective than current drugs used for dermatological conditions, but will produce less toxicities, says the professor and chairman of dermatology at Wake Forest University School of Medicine, Winston-Salem, N. C.